MDT
Medtronic plc · Healthcare · Medical - Devices
Momentum inputs (comparable managers):
holder breadth -7.4% ·
share flow -0.8% ·
net new positions -12.0%
— formula
Broad distribution — falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 172 | +1 | 851.51M | $67.87B | +6 | −7 |
| Q1 2026 | 176 | +1 | 881.81M | $77.21B | +3 | −3 |
| Q4 2025 | 174 | 0 | 922.24M | $88.62B | +1 | — |
| Q3 2025 | 25 | -2 | 519.60M | $49.51B | — | −3 |
| Q2 2025 | 25 | +1 | 407.26M | $35.53B | +1 | — |
| Q1 2025 | 21 | 0 | 149.92M | $13.50B | +1 | −1 |
| Q4 2024 | 21 | -1 | 154.76M | $12.40B | — | −1 |
| Q3 2024 | 21 | +1 | 104.49M | $9.40B | +1 | — |
| Q2 2024 | 20 | — | 97.49M | $7.67B | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passive) | 127.07M | +0.1% | $12.10B | 0.2% | ▲ Add | 2 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (passive) | 119.57M | -2.4% | $11.39B | 0.2% | ▼ Trim | 2 | SEC ↗ ×22 |
| 3 | JPMorgan Chase ✦ | 104.39M | — | $9.94B | 0.3% | n/c | 1 | SEC ↗ ×42 |
| 4 | State Street Global Advisors ✦ (passive) | 60.46M | +1.1% | $5.80B | 0.2% | ▲ Add | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 27.65M | -2.0% | $2.62B | 0.2% | ▼ Trim | 6 | SEC ↗ ×2 |
| 6 | Morgan Stanley ✦ | 20.23M | — | $1.93B | 0.1% | n/c | 1 | SEC ↗ ×20 |
| 7 | Wellington Management ✦ | 10.19M | +35.3% | $970.46M | 0.2% | ▲ Add | 6 | SEC ↗ ×8 |
| 8 | Goldman Sachs Group ✦ | 8.16M | — | $777.61M | 0.1% | n/c | 1 | SEC ↗ ×5 |
| 9 | Dodge & Cox ✦ | 7.73M | -0.2% | $735.74M | 0.4% | ▼ Trim | 6 | SEC ↗ |
| 10 | Capital World Investors ✦ | 6.58M | +19.2% | $626.58M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 5.92M | -2.0% | $564.17M | 0.1% | ▼ Trim | 6 | SEC ↗ ×2 |
| 12 | Millennium Management ✦ | 4.81M | +19.5% | $457.92M | 0.4% | ▲ Add | 6 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 3.70M | -62.2% | $352.53M | 0.3% | ▼ Trim | 6 | SEC ↗ ×2 |
| 14 | AQR Capital Management ✦ | 3.33M | +68.3% | $314.40M | 0.2% | ▲ Add | 6 | SEC ↗ ×7 |
| 15 | Arrowstreet Capital ✦ | 2.43M | +62.6% | $231.50M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 16 | Fidelity (FMR) ✦ | 2.37M | +46.0% | $225.51M | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 17 | Adage Capital Partners ✦ | 2.18M | +20.8% | $207.67M | 0.3% | ▲ Add | 6 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 1.05M | -56.1% | $100.27M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 19 | Baillie Gifford ✦ | 478.21K | -3.0% | $45.55M | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 20 | Bridgewater Associates ✦ | 338.20K | +67.3% | $32.21M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 21 | Gotham Asset Management ✦ | 288.01K | +11.7% | $27.43M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 22 | Fisher Asset Management ✦ | 239.53K | -12.6% | $22.81M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 23 | Two Sigma Investments ✦ | 217.24K | -74.8% | $20.69M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 24 | Marshall Wace ✦ | 209.77K | +30.8% | $19.98M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 25 | PRIMECAP Management ✦ | 3.82K | -99.2% | $363,818 | 0.0% | ▼ Trim | 6 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Norges Bank | $1.43B | was 0.2% |
| Renaissance Technologies | $37.70M | was 0.1% |
| Point72 Asset Management | $27.95M | was 0.1% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 2,204 holders, 1.04B shares, $87.65B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 1.48K sh · $138,883
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology